You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Olorofim

Showing 1 - 20 of 20
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Impairment Trial in Orlando (Olorofim)

Recruiting
  • Renal Impairment
  • Olorofim
  • Orlando, Florida
    Omega Research
Aug 1, 2022

Hepatic Impairment Trial in Tustin, Orlando (Olorofim)

Completed
  • Hepatic Impairment
  • Olorofim
  • Tustin, California
  • +1 more
Mar 15, 2022

Invasive Aspergillosis Trial in Pathum Wan (Olorofim, AmBisome®)

Recruiting
  • Invasive Aspergillosis
  • Sacramento, California
  • +44 more
Dec 16, 2022

Healthy Trial in Leeds (Olorofim)

Completed
  • Healthy
  • Olorofim
  • Leeds, West Yorkshire, United Kingdom
    Covance Clinical Research Unit
Jan 7, 2021

Healthy Trial in London (Itraconazole oral solution, Rifampicin Oral Capsule, Olorofim)

Completed
  • Healthy
  • Itraconazole oral solution
  • +2 more
  • London, United Kingdom
    Hammersmith Medicines Research
Jul 23, 2020

Invasive Fungal Infections Trial in Groningen (Olorofim)

Completed
  • Invasive Fungal Infections
  • Olorofim
  • Groningen, Netherlands
    PRA Health Sciences
Nov 11, 2019

Invasive Fungal Infections Trial in Worldwide (F901318)

Recruiting
  • Invasive Fungal Infections
  • Bakersfield, California
  • +83 more
Nov 30, 2022

Invasive Aspergillosis Trial in Nottingham (IV F901318, Oral F901318)

Withdrawn
  • Invasive Aspergillosis
  • IV F901318
  • Oral F901318
  • Nottingham, Nottinghamshire, United Kingdom
    Quotient Clinical
Jul 24, 2019

Invasive Aspergillosis Trial in Leeds (F901318)

Completed
  • Invasive Aspergillosis
  • Leeds, West Yorkshire, United Kingdom
    Covance Clinical Research Unit
Jul 31, 2018

Acute Myeloid Leukemia Trial (F901318 with fluconazole low dose, F901318 with fluconazole high dose, F901318 with posaconazole)

Withdrawn
  • Acute Myeloid Leukemia
  • F901318 with fluconazole low dose
  • +2 more
  • (no location specified)
Feb 13, 2018

Pulmonary Aspergillosis - Invasive, Acute Myeloid Leukemia Trial (F901318, Caspofungin)

Withdrawn
  • Pulmonary Aspergillosis - Invasive
  • Acute Myeloid Leukemia
  • (no location specified)
Feb 13, 2018

Invasive Aspergillosis Trial (F901318)

Withdrawn
  • Invasive Aspergillosis
  • (no location specified)
Oct 30, 2017

Invasive Aspergillosis Trial (cyclosporine A, Posaconazole, Pantoprazole)

Withdrawn
  • Invasive Aspergillosis
  • cyclosporine A
  • +4 more
  • (no location specified)
Oct 30, 2017

Invasive Aspergillosis Trial in Merthyr Tydfil (F901318 Dose level A oral, Placebo dose level A oral, F901318 Dose level B oral)

Completed
  • Invasive Aspergillosis
  • F901318 Dose level A oral
  • +5 more
  • Merthyr Tydfil, Glamorgan, United Kingdom
    Simbec Research Ltd
May 22, 2017

Invasive Aspergillosis Trial in Nottingham (F901318 SDD, F901318 IR, F901318 IR Fasting)

Completed
  • Invasive Aspergillosis
  • F901318 SDD
  • +3 more
  • Nottingham, United Kingdom
    Quotient Clinical
Nov 25, 2016

Invasive Aspergillosis Trial in Belfast (F901318, Fluconazole)

Completed
  • Invasive Aspergillosis
  • Belfast, Northern Ireland, United Kingdom
    CELERION
Feb 1, 2017

Invasive Aspergillosis Trial in London (F901318, Placebo)

Completed
  • Invasive Aspergillosis
  • London, UK, United Kingdom
    Hammersmith Medicines Research
Sep 16, 2016

Invasive Aspergillosis Trial in London (Midazolam with F901318)

Completed
  • Invasive Aspergillosis
  • Midazolam with F901318
  • London, United Kingdom
    Hammersmith Medicines Research
Jun 8, 2016

Invasive Aspergillosis Trial in Merthyr Tydfil (F901318 safety, F901318 tolerability, F901318 pharmacokinetics)

Completed
  • Invasive Aspergillosis
  • F901318 safety
  • +5 more
  • Merthyr Tydfil, Wales, United Kingdom
    Simbec Orion
Sep 16, 2016

Invasive Aspergillosis Trial in Merthyr Tydfil (F901318, Placebo)

Completed
Has Results
  • Invasive Aspergillosis
  • Merthyr Tydfil, Mid Glamorgan, United Kingdom
    Simbec Research
Aug 10, 2015